CClinicalTrials.gg
CompletedNCT02718976Updated Apr 26, 2016

Shamrock - Ultrasound/MR Image Fusion Guided Lumbar Plexus Block

A Phase 2 interventional study of Ultrasound/MR image fusion guided lumbar plexus block (Shamrock) and Ultrasound guided lumbar plexus block (Shamrock) in Hip Fractures, Anesthesia, Local and Pain, Postoperative, sponsored by University of Aarhus. Completed. Open to participants aged 18 Years to 85 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2016-04-26.

Sponsored by University of Aarhus · Phase 2, Interventional, and Treatment

Phase
Phase 2
Study type
Interventional
Enrollment
22
Allocation
Randomized
Ages
18 Years to 85 Years
Sex
All
01

Study summary

The main objective is to complete a double-blinded randomized controlled crossover trial of lumbar plexus block with the Shamrock technique guided by ultrasound (US)/magnetic resonance imaging (MRI) image fusion vs. the Shamrock technique guided by ultrasound in healthy volunteers.

The investigators will assess block procedure-related parameters, anatomical spread of local anesthetic, and motor and sensory effects.

02

Conditions studied

  • Hip Fractures
  • Anesthesia, Local
  • Pain, Postoperative

Keywords

  • Hip surgery anesthesia
  • Perioperative analgesia
03

In context

Pain, Postoperative

5,093 studies on the registry are indexed under Pain, Postoperative; 1,140 are open to participants now.

This study's enrollment of 22 is below the median of 75 across 4,344 interventional studies indexed under Pain, Postoperative.

Browse Pain, Postoperative studies →

Lead sponsor

University of Aarhus is the lead sponsor of 1,274 studies on the registry; 183 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Age ≥ 18 years
  • Body mass index (BMI): 18.5 ≤ BMI ≤30
  • Written and oral consent to participate
  • Normal healthy person (American Society of Anesthesiology Classification I)

Exclusion criteria

Exclusion Criteria:

  • Volunteers not abel to speak or understand Danish
  • Volunteers not able to cooperate
  • Allergy against the medicines used in the study
  • Daily use of analgesics
  • Drug abuse - according to the investigator's judgment
  • Alcohol consumption greater than the recommendations of the Danish National Board of Health
  • Contraindication for MRI scan (including pregnancy)
  • Volunteers in whom nerve blocks are impossible due to technical reasons or infection
  • Volunteers who are incompetent, eg. surrogate consent is unaccepted
05

Study design

Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
22 participants (actual)

Study arms

  • Experimental
    Shamrock guided by US/MR image fusion

    Use of US/MR image fusion guided Shamrock technique to place lumbar plexus block (20 ml 2% lidocaine with epinephrine added gadoterate meglumine).

    Procedure: Ultrasound/MR image fusion guided lumbar plexus block (Shamrock) · Drug: Lidocaine-epinephrine added gadoterate meglumine

  • Other
    Shamrock guided by US

    Use of US guided Shamrock technique to place lumbar plexus block (20 ml 2% lidocaine with epinephrine added gadoterate meglumine).

    Procedure: Ultrasound guided lumbar plexus block (Shamrock) · Drug: Lidocaine-epinephrine added gadoterate meglumine

Interventions

  • ProcedureUltrasound/MR image fusion guided lumbar plexus block (Shamrock)
  • ProcedureUltrasound guided lumbar plexus block (Shamrock)
  • DrugLidocaine-epinephrine added gadoterate meglumine

    Perineural injection of 20 ml 2% lidocaine with 0.0005% epinephrine added 1 ml of gadoterate meglumine (0.13 ml) and sodium chloride (NaCl, 0.87 ml). The 1 ml of gadoterate meglumine-NaCl is added to the local anesthetic prior to the perineural injection in order to enhance visualization of the local anesthetic on MRI scanning after the intervention.

06

What researchers measure

Primary outcomes

  1. Number of participants with a successful block of the femoral and obturator nerves (reduced muscle force compared to baseline assessed with handheld dynamometer), and of the lateral femoral cutaneous nerve (assessed with cold and pinprick test)

    Block success is defined as the number of volunteers with a successful motor block of the femoral nerve and the obturator nerve, and with a successful sensory block of the lateral femoral cutaneous nerve. Motor block is a proxy marker of sensory block. A participant with a successful motor block has reduced muscle force after block compared to baseline muscle force assessed with handheld dynamometer, and a participant with a successful sensory block has decreased/absent sensation for cold and/or pinprick.

    Time frame: Assessed 60 minutes after intervention. Data will be presented 10 months after study completion.

Secondary outcomes

  1. Time for preparation of block procedure (seconds)

    Time for block preparation is defined as the time period from the time point when the volunteer is placed on the block bed to the time point when the pre-ultrasound scanning before intervention is complete.

    Time frame: Assessed 3 minutes prior to intervention. Data will be presented 10 months after study completion.

  2. Time for block procedure (seconds)

    Time for block procedure is defined as the time period from the time point when the ultrasound probe is placed on the skin after completed preparation to the time point when the block needle is pulled out after injection of local anesthetics (end of intervention).

    Time frame: Assessed 0 minutes after intervention. Data will be presented 10 months after study completion.

  3. Electrical nerve stimulation strength (mA)

    Minimal electrical nerve stimulation (mA) required to trigger neuromuscular response and confirm correct placement of block needle prior to injection of local anesthetics.

    Time frame: Assessed 1 minute before injection of injectate. Data will be presented 10 months after study completion.

  4. Electrical nerve stimulation response (quadriceps, sartorius, other muscular, paresthesia, none)

    Type of neuromuscular response on electrical nerve stimulation.

    Time frame: Assessed 1 minute before injection of injectate. Data will be presented 10 months after study completion.

  5. Needle advancements

    Number of needle advancements during intervention.

    Time frame: Assessed 0 minutes after intervention. Data will be presented 10 months after study completion.

  6. Injection site

    Time frame: Assessed 0 minutes after intervention. Data will be presented 10 months after study completion.

  7. Block needle depth

    Time frame: Assessed 0 minutes after intervention. Data will be presented 10 months after study completion.

  8. Discomfort

    Estimated on numeric rating scale 0-10

    Time frame: Assessed 0 minutes after intervention. Data will be presented 10 months after study completion.

  9. Mean arterial pressure change

    Time frame: Mean arterial pressure is measured prior to intervention and 5 min after intervention. Data will be presented 10 months after study completion.

  10. Number of participants with visual confirmed contact between the injectate and the spinal nerves L2-S1, the femoral, the obturator, and the lateral femoral cutaneous nerves, and the lumbosacral trunk assessed on MRI

    Time frame: Assessed on MRI sampled 10-40 minutes after intervention. Data will be presented 10 months after study completion.

  11. Number of participants with visually confirmed epidural spread of the injectate assessed on MRI.

    Time frame: Assessed on MRI sampled 10-40 minutes after intervention. Data will be presented 10 months after study completion.

  12. Number of participants with motor block

    Muscle strength of the femoral, obturator, superior gluteal, and sciatic nerves are estimated with handheld dynamometer during knee extension, hip adduction, hip abduction, and knee flexion. Motor block is assessed as reduced muscle strength compared to baseline.

    Time frame: Baseline muscle strength is estimated prior to first intervention. Post-block muscle strength is estimated 60 minutes after intervention. Data will be presented 10 months after study completion.

  13. Number of participants with sensory block

    Sensory block is defined as decreased or absent sensation for cold, warmth, touch, and pinprick are assessed for the dermatomes T8-S3 and the lateral femoral cutaneous nerve.

    Time frame: Estimated 70 minutes after intervention. Data will be presented 10 months after study completion.

  14. Cost-effectiveness (ICER)

    ICER is estimated as the difference in mean marginal cost of the blocks.

    Time frame: Calculated 1 month after study completion. Data will be presented 10 months after study completion.

  15. Quantitative diffusion weighted MRI reproducibility

    Time frame: Assessed on MRI sampled 40-55 minutes after intervention. Data will be presented 10 months after study completion.

  16. Image evaluation of diffusion weighted MRI reproducibility

    Time frame: Assessed on MRI sampled 40-55 minutes after intervention. Data will be presented 10 months after study completion.

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 26, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02718976
Lead sponsor
University of Aarhus
Collaborators
Bendtsen, Thomas Fichtner, M.D, Ph.D., AP Moeller Foundation, Aarhus University Hospital
Responsible party
Sponsor
First posted
Mar 24, 2016
Start date
Mar 2016
Primary completion
Apr 2016
Completion
Apr 2016
Last update
Apr 26, 2016

Study contacts

Jennie MC Strid, M.D.
principal investigator · Department of Anesthesiology and Intensive Care, Aarhus University Offical

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion